SYNLAB Group is an international medical diagnostics provider headquartered in Munich, Germany.

[2][3] In 1998, together with his partners, Bartl Wimmer founded SYNLAB GmbH in Augsburg, Germany, as an association of freelance laboratory physicians.

In 2010, SYNLAB merged with the two laboratory providers, Futurelab and Fleming Labs, which laid the groundwork for several further acquisitions.

[4][5] In August 2015, the private equity company Cinven acquired French laboratory service provider Labco.

The company performed 600 million laboratory tests and achieved sales revenues of approximately 3.25 billion euros in 2022.

[28] SYNLAB provides medical diagnostic services to practising doctors, hospitals and clinics, governments, and corporates.

[1][22] SYNLAB's multidisciplinary range of services includes, in the field of human medicine, clinical chemistry, haematology, coagulation, microbiology, serology, immunology, genetics, molecular biology, pathology, cytology, endocrinology, and maternity care.

[29] The SYNLAB laboratories examine 600 million samples (e.g. urine, blood, tissue) every year on the basis of around 5,000 different test parameters.